Literature DB >> 32278006

Eosinophil diversity in asthma.

Glenn Van Hulst1, Hashini M Batugedara2, Joseph Jorssen1, Renaud Louis3, Fabrice Bureau4, Christophe J Desmet5.   

Abstract

Eosinophils are a type of granulated innate immune cells that have long been implicated in a specific type of asthma, referred to as eosinophilic asthma. Several immunotherapeutics that target and deplete eosinophils or limit their numbers are currently widely used and provide improved disease outcome in severe eosinophilic asthma. Current clinical results provide conclusive evidence of a generally detrimental role of eosinophils in asthma. Yet, a small but growing body of reports suggests that eosinophils may be more diverse than currently appreciated. In this review, we explore pre-clinical and clinical evidence that suggests the existence of eosinophil subsets with potentially distinct functional roles in asthma. We conclude by discussing state-of-the-art strategies for deciphering heterogeneity of this complex cell type, and argue this knowledge could translate into the improved personalized treatment of severe eosinophilic asthma.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; Eosinophil; Immune cell subsets; Immunotherapy; Interleukin-5

Year:  2020        PMID: 32278006     DOI: 10.1016/j.bcp.2020.113963

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

Review 1.  Eosinophils and Lung Cancer: From Bench to Bedside.

Authors:  Anne Sibille; Jean-Louis Corhay; Renaud Louis; Vincent Ninane; Guy Jerusalem; Bernard Duysinx
Journal:  Int J Mol Sci       Date:  2022-05-03       Impact factor: 6.208

2.  Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.

Authors:  Elizabeth A Jacobsen; David J Jackson; Enrico Heffler; Sameer K Mathur; Albert J Bredenoord; Ian D Pavord; Praveen Akuthota; Florence Roufosse; Marc E Rothenberg
Journal:  Annu Rev Immunol       Date:  2021-03-01       Impact factor: 28.527

Review 3.  Intestinal eosinophils, homeostasis and response to bacterial intrusion.

Authors:  Alessandra Gurtner; Ignacio Gonzalez-Perez; Isabelle C Arnold
Journal:  Semin Immunopathol       Date:  2021-04-30       Impact factor: 9.623

Review 4.  Immunopathology of RSV: An Updated Review.

Authors:  Harrison C Bergeron; Ralph A Tripp
Journal:  Viruses       Date:  2021-12-10       Impact factor: 5.048

5.  Real world effectiveness of benralizumab on respiratory function and asthma control.

Authors:  Francesco Menzella; Matteo Fontana; Carla Galeone; Giulia Ghidoni; Silvia Capobelli; Patrizia Ruggiero; Chiara Scelfo; Anna Simonazzi; Chiara Catellani; Francesco Livrieri; Nicola Cosimo Facciolongo
Journal:  Multidiscip Respir Med       Date:  2021-10-04

6.  RSV Infection in Neonatal Mice Induces Pulmonary Eosinophilia Responsible for Asthmatic Reaction.

Authors:  Dan Zhang; Jie Yang; Yuanhui Zhao; Jinjun Shan; Lingling Wang; Guang Yang; Susu He; Erguang Li
Journal:  Front Immunol       Date:  2022-02-02       Impact factor: 7.561

7.  IL-9 neutralizing antibody suppresses allergic inflammation in ovalbumin-induced allergic rhinitis mouse model.

Authors:  He Zhao; Zhaowei Gu; Yunxiu Wang; Meng Wang; Yue Zhan; Xin Zhao; Zhiwei Cao
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

8.  Impact of controlled high-sucrose and high-fat diets on eosinophil recruitment and cytokine content in allergen-challenged mice.

Authors:  Caroline M Percopo; Morgan McCullough; Ajinkya R Limkar; Kirk M Druey; Helene F Rosenberg
Journal:  PLoS One       Date:  2021-08-12       Impact factor: 3.240

9.  Poly-L-arginine promotes asthma angiogenesis through induction of FGFBP1 in airway epithelial cells via activation of the mTORC1-STAT3 pathway.

Authors:  Xu Chen; Manli Miao; Meng Zhou; Jie Chen; Dapeng Li; Ling Zhang; Anjiang Sun; Minglong Guan; Zixi Wang; Ping Liu; Shengquan Zhang; Xiaojun Zha; Xiaoyun Fan
Journal:  Cell Death Dis       Date:  2021-08-02       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.